Moreover, the cell death rate of TetOn‐YY2 Trans cells was significantly lower than HCT116 cells, which were CIN‐negative (Figure 6J), suggesting that CIN level before oxaliplatin treatment contribute to the observed differences in viability between cells with continuous and transient YY2 overexpression. The gene discussed is YY2; the disease is cervical squamous intraepithelial neoplasia.